[Leadless pacemakers: results of a survey from implanter centers in the Lombardy region].

Pacemaker leadless: risultati di una survey condotta nei centri impiantatori della Regione Lombardia.

Journal

Giornale italiano di cardiologia (2006)
ISSN: 1972-6481
Titre abrégé: G Ital Cardiol (Rome)
Pays: Italy
ID NLM: 101263411

Informations de publication

Date de publication:
Feb 2022
Historique:
entrez: 28 3 2022
pubmed: 29 3 2022
medline: 1 4 2022
Statut: ppublish

Résumé

Transvenous pacing is nowadays the cornerstone of interventional management of bradyarrhythmias. It is still associated, however, with significant complications, mostly related to indwelling transvenous leads or device pocket. In order to reduce these complications, leadless pacemakers have been recently introduced into clinical practice, but no guidelines are yet available to indicate who are those patients that might benefit the most and whether leadless pacing should be preferred in the old or young population. This survey aims to describe the use of leadless pacemaker devices in a real-world setting. Eleven arrhythmia centers in the Lombardy region (out of a total of 17 participating centers) responded to the proposed questionnaire regarding patient characteristics and indications to leadless pacing. Out of a total of 411 patients undergoing leadless pacing during 4.2 ± 0.98 years, the median age was 77 years, with 0.18% of patients having less than 18 years, 29.9% 18-65 years, 34.3% 65-80 years and 35.6% >80 years. The most common indication was slow atrial fibrillation (49% of patients), followed by atrioventricular block and sinoatrial dysfunction. Two centers reported in-hospital complications. Leadless pacemakers proved to be a safe pacing strategy actually destined mostly to elderly patients.

Sections du résumé

BACKGROUND BACKGROUND
Transvenous pacing is nowadays the cornerstone of interventional management of bradyarrhythmias. It is still associated, however, with significant complications, mostly related to indwelling transvenous leads or device pocket. In order to reduce these complications, leadless pacemakers have been recently introduced into clinical practice, but no guidelines are yet available to indicate who are those patients that might benefit the most and whether leadless pacing should be preferred in the old or young population. This survey aims to describe the use of leadless pacemaker devices in a real-world setting.
METHODS METHODS
Eleven arrhythmia centers in the Lombardy region (out of a total of 17 participating centers) responded to the proposed questionnaire regarding patient characteristics and indications to leadless pacing.
RESULTS RESULTS
Out of a total of 411 patients undergoing leadless pacing during 4.2 ± 0.98 years, the median age was 77 years, with 0.18% of patients having less than 18 years, 29.9% 18-65 years, 34.3% 65-80 years and 35.6% >80 years. The most common indication was slow atrial fibrillation (49% of patients), followed by atrioventricular block and sinoatrial dysfunction. Two centers reported in-hospital complications.
CONCLUSIONS CONCLUSIONS
Leadless pacemakers proved to be a safe pacing strategy actually destined mostly to elderly patients.

Identifiants

pubmed: 35343516
doi: 10.1714/3735.37214
doi:

Types de publication

Journal Article

Langues

ita

Sous-ensembles de citation

IM

Pagination

120-127

Auteurs

Luca Rosario Limite (LR)

U.O. Aritmologia ed Elettrofisiologia, Dipartimento Cardio-Toraco-Vascolare, IRCCS Ospedale San Raffaele, Milano.

Massimo Mantica (M)

Centro di Elettrofisiologia Cardiaca ed Elettrostimolazione, Istituto Clinico Sant'Ambrogio, Milano.

Giusy Sirico (G)

Centro di Elettrofisiologia Cardiaca ed Elettrostimolazione, Istituto Clinico Sant'Ambrogio, Milano.

Giovanni Rovaris (G)

U.O. Cardiologia, ASST San Gerardo, Monza (MB).

Elisabetta MOntemerlo (E)

U.O. Cardiologia, ASST San Gerardo, Monza (MB).

Domenico Pecora (D)

Fondazione Poliambulanza Istituto Ospedaliero, Brescia.

Massimo Pagani (M)

U.O. Cardiologia, Ospedale Civile di Legnano, Legnano (MI).

Luigi Fedele (L)

U.O. Cardiologia, Ospedale Civile di Legnano, Legnano (MI).

Giuseppe Augello (G)

U.O. Cardiologia, Istituto Clinico Città Studi, Milano.

Francesca Zuffada (F)

U.O. Cardiologia, Istituto Clinico Città Studi, Milano.

Roberto Rordorf (R)

U.O. Aritmologia, IRCCS Fondazione Policlinico San Matteo, Pavia.

Francesco Ambrosini (F)

U.O. Malattie dell'Apparato Cardiovascolare, Dipartimento di Medicina Interna, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Milano.

Lorenzo Gigli (L)

U.O. Malattie dell'Apparato Cardiovascolare, Dipartimento di Medicina Interna, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano, Milano.

Paolo De Filippo (P)

U.O. Elettrofisiologia ed Elettrostimolazione Cardiaca, Ospedale Papa Giovanni XXIII, Bergamo.

Antonio Pani (A)

U.O. Cardiologia-UTIC, Ospedale di Lecco.

Giovanni Forleo (G)

U.O. Cardiologia, Ospedale Luigi Sacco, Milano.

Gianfranco Mitacchione (G)

U.O. Cardiologia, Ospedale Luigi Sacco, Milano.

Paolo Della Bella (P)

U.O. Aritmologia ed Elettrofisiologia, Dipartimento Cardio-Toraco-Vascolare, IRCCS Ospedale San Raffaele, Milano.

Patrizio Mazzone (P)

U.O. Aritmologia ed Elettrofisiologia, Dipartimento Cardio-Toraco-Vascolare, IRCCS Ospedale San Raffaele, Milano.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH